These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6120659)

  • 1. Perception of tardive dyskinesia in outpatients receiving maintenance neuroleptics.
    Rosen AM; Mukherjee S; Olarte S; Varia V; Cardenas C
    Am J Psychiatry; 1982 Mar; 139(3):372-4. PubMed ID: 6120659
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationship of awareness of dyskinesia in schizophrenia to insight into mental illness.
    Arango C; Adami H; Sherr JD; Thaker GK; Carpenter WT
    Am J Psychiatry; 1999 Jul; 156(7):1097-9. PubMed ID: 10401460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comment on "tardive dyskinesia circa 2006".
    Rosenheck RA
    Am J Psychiatry; 2007 Jan; 164(1):170; author reply 170. PubMed ID: 17202564
    [No Abstract]   [Full Text] [Related]  

  • 4. Negative symptoms, tardive dyskinesia and depression in chronic schizophrenia.
    Barnes TR; Liddle PF; Curson DA; Patel M
    Br J Psychiatry Suppl; 1989 Nov; (7):99-103. PubMed ID: 2575915
    [No Abstract]   [Full Text] [Related]  

  • 5. [Schizophrenic deficit syndrome and neurologic tolerance].
    Verdoux H; Bourgeois M
    Encephale; 1996 Jun; 22 Spec No 2():45-7. PubMed ID: 8767042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing epidemiology of tardive dyskinesia: an overview.
    Jeste DV; Wyatt RJ
    Am J Psychiatry; 1981 Mar; 138(3):297-309. PubMed ID: 6110344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors in the development of severe forms of tardive dyskinesia.
    Yassa R; Nair NP; Iskander H; Schwartz G
    Am J Psychiatry; 1990 Sep; 147(9):1156-63. PubMed ID: 1974745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia.
    Sirota P; Mosheva T; Shabtay H; Giladi N; Korczyn AD
    Am J Psychiatry; 2000 Feb; 157(2):287-9. PubMed ID: 10671405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tardive dystonia induced by atypical neuroleptics: a case report with olanzapine.
    Charfi F; Cohen D; Houeto JL; Soubrié C; Mazet P
    J Child Adolesc Psychopharmacol; 2004; 14(1):149-52. PubMed ID: 15142403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The coexistence of parkinsonism-like symptoms and tardive dyskinesia.
    Richardson MA; Craig TJ
    Am J Psychiatry; 1982 Mar; 139(3):341-3. PubMed ID: 6120656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of tardive dyskinesia by single and repeated application of 7-methoxytacrin.
    Hanus H; Tůtma I; Zapletálek M; Fusek J; Hrdina V
    Homeost Health Dis; 1991; 33(5-6):301-4. PubMed ID: 18265509
    [No Abstract]   [Full Text] [Related]  

  • 12. New-onset tardive dyskinesia in patients with first-episode psychosis receiving risperidone or haloperidol.
    Gharabawi GM; Bossie CA; Zhu Y
    Am J Psychiatry; 2006 May; 163(5):938-9. PubMed ID: 16648343
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of verapamil on tardive dyskinesia and psychosis in schizophrenic patients.
    Reiter S; Adler L; Angrist B; Peselow E; Rotrosen J
    J Clin Psychiatry; 1989 Jan; 50(1):26-7. PubMed ID: 2562952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tardive dyskinesia with special emphasis on tardive dyskinesia caused by neuroleptics].
    Preradović M; Ilić T; Bjelica N
    Vojnosanit Pregl; 1996; 53(6):519-26. PubMed ID: 9229972
    [No Abstract]   [Full Text] [Related]  

  • 15. Early-onset tardive dyskinesia in a neuroleptic-naive patient exposed to paliperidone.
    Hsu WY; Chiu NY
    J Clin Psychopharmacol; 2013 Oct; 33(5):712-3. PubMed ID: 23899637
    [No Abstract]   [Full Text] [Related]  

  • 16. [Patient knowledge regarding tardive dyskinesia].
    Haberfellner EM; Rittmannsberger H
    Nervenarzt; 2006 Mar; 77(3):333-7. PubMed ID: 16552613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-perception of tardive dyskinesia and neuroleptic-induced parkinsonism: a study of clinical correlates.
    Lohr JB; Lohr MA; Wasli E; Hilliard B; Larson L; Vardiman E; Wade L; Jeste DV
    Psychopharmacol Bull; 1987; 23(1):211-4. PubMed ID: 2885888
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical forms of severe tardive dyskinesia.
    Gardos G; Cole JO; Salomon M; Schniebolk S
    Am J Psychiatry; 1987 Jul; 144(7):895-902. PubMed ID: 2886062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of severe and mild tardive dyskinesia: implications for etiology.
    Gardos G; Cole JO; Schniebolk S; Salomon M
    J Clin Psychiatry; 1987 Sep; 48(9):359-62. PubMed ID: 2887550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The profile of cognitive impairment in elderly dyskinetic subjects.
    Karson CN; Lyon N; Amick R; Bracha HS; Guggenheim FG
    J Neuropsychiatry Clin Neurosci; 1993; 5(1):61-5. PubMed ID: 8094020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.